» Articles » PMID: 35711262

Predictive Factors of Acute Symptomatic Seizures in Patients With Ischemic Stroke Due to Large Vessel Occlusion

Overview
Journal Front Neurol
Specialty Neurology
Date 2022 Jun 17
PMID 35711262
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Acute symptomatic seizures (ASz) after ischemic stroke are associated with increased mortality; therefore, identifying predictors of ASz is important. The purpose of this study was to analyze predictors of ASz in a population of patients with ischemic stroke due to large arterial vessel occlusion (LVO).

Materials And Methods: This retrospective study examined patients with acute ischemic stroke caused by LVO between 2016 and 2020. Identification of predictive factors was performed using univariate and subsequent multiple logistic regression analysis. In addition, subgroup analysis regarding seizure semiology and time of seizure occurrence (≤ 24 h and > 24 h after stroke) was performed.

Results: The frequency of ASz among 979 patients was 3.9 % ( = 38). Univariate logistic regression analysis revealed an increased risk of ASz in patients with higher National Institutes of Health Stroke Scale (NIHSS) score at admission or 24 h after admission, hypernatremia at admission ≥ 145 mmol/L, and pneumonia. Further multiple logistic regression analysis revealed that NIHSS 24 h after admission was the strongest predictor of ASz, particularly relating to ASz occurring later than 24 h after stroke. Patients who experienced a seizure within the first 24 h after stroke were more likely to have a generalized tonic-clonic (GTCS) and focal motor seizure; beyond 24 h, seizures with impaired awareness and non-convulsive status epilepticus were more frequent.

Conclusion: NIHSS score 24 h after admission is a strong predictive factor for the occurrence of ASz in patients with ischemic stroke caused by LVO. The semiology of ASz varied over time, with GTCS occurring more frequently in the first 24 h after stroke.

Citing Articles

Trends and cost structure of drug-based secondary prevention of ischemic strokes.

Kohlhase K, Bohmann F, Grefkes C, Strzelczyk A, Willems L Neurol Res Pract. 2025; 7(1):1.

PMID: 39743621 PMC: 11697035. DOI: 10.1186/s42466-024-00356-x.


Effect of Intravenous Thrombolysis and Mechanical Thrombectomy on the Incidence of Acute Symptomatic Seizure and Post-Stroke Epilepsy in Patients with Acute Large-Vessel Occlusion.

Ishihara H, Kohyama S, Nishida S, Kumagai K, Hayashi S, Kato H J Neuroendovasc Ther. 2024; 18(8):207-212.

PMID: 39166095 PMC: 11333155. DOI: 10.5797/jnet.oa.2024-0007.


Clinical approaches for poststroke seizure: a review.

Ryu H, Kim H, Shin B, Kang H Front Neurol. 2024; 15:1337960.

PMID: 38660095 PMC: 11039895. DOI: 10.3389/fneur.2024.1337960.


Large-vessel-occlusion in patients with previous ischemic stroke: an analysis of adherence to secondary preventive medication for different etiologies.

Kohlhase K, Schafer J, Tako L, Willems L, Hattingen E, Bohmann F Neurol Res Pract. 2023; 5(1):22.

PMID: 37226225 PMC: 10210396. DOI: 10.1186/s42466-023-00247-7.


Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference?.

Nilo A, Pauletto G, Lorenzut S, Merlino G, Verriello L, Janes F J Clin Med. 2023; 12(3).

PMID: 36769417 PMC: 9918271. DOI: 10.3390/jcm12030769.


References
1.
Beghi E, DAlessandro R, Beretta S, Consoli D, Crespi V, Delaj L . Incidence and predictors of acute symptomatic seizures after stroke. Neurology. 2011; 77(20):1785-93. DOI: 10.1212/WNL.0b013e3182364878. View

2.
Schaller-Paule M, Foerch C, Bohmann F, Lapa S, Misselwitz B, Kohlhase K . Predicting Poststroke Pneumonia in Patients With Anterior Large Vessel Occlusion: A Prospective, Population-Based Stroke Registry Analysis. Front Neurol. 2022; 13:824450. PMC: 8893016. DOI: 10.3389/fneur.2022.824450. View

3.
Galovic M, Dohler N, Erdelyi-Canavese B, Felbecker A, Siebel P, Conrad J . Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study. Lancet Neurol. 2018; 17(2):143-152. DOI: 10.1016/S1474-4422(17)30404-0. View

4.
von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007; 370(9596):1453-7. DOI: 10.1016/S0140-6736(07)61602-X. View

5.
Bladin C, Alexandrov A, Bellavance A, Bornstein N, Chambers B, Cote R . Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000; 57(11):1617-22. DOI: 10.1001/archneur.57.11.1617. View